Expert Insights from Lexicomp

Advising patients on cannabis use can be challenging for clinicians – while it’s legal or approved for medical use in many U.S. states, because it’s illegal at the federal level, there’s lack of clinical standards and knowledge about interactions.

A review of case data found that more than 70% of COVID-19 patients received antimicrobial treatment despite less than 10% having bacterial or fungal co-infections – amplifying risks for antimicrobial resistance. Experts discuss how to change that.

With so much misinformation about the COVID-19 vaccines and retail pharmacies joining this unprecedented public health effort, let’s address common questions on efficacy, safety, and side effects.

As major retail pharmacies join the COVID-19 vaccination effort, a Medical Reserve Corps volunteer and vaccine administrator discusses the four priorities care administrators need to focus on now.

The recently held National Community Pharmacists Association (NCPA) Annual Meeting provided an upbeat picture of community pharmacies trying to meet continuing pricing pressures by focusing on value-based services.

Change can mean innovation and growth. But change can also mean disruption, high costs, and breakdowns in processes.

Two years ago, I wrote a blog about health information exchange (HIE) and the role of the pharmacist in this important component of patient care.

As we approach the midyear point, it’s a great opportunity to benchmark several key trends that are challenging both the pharmacy business and profession and compare them to the...

Advising patients on cannabis use can be challenging for clinicians – while it’s legal or approved for medical use in many U.S. states, because it’s illegal at the federal level, there’s lack of clinical standards and knowledge about interactions.

A review of case data found that more than 70% of COVID-19 patients received antimicrobial treatment despite less than 10% having bacterial or fungal co-infections – amplifying risks for antimicrobial resistance. Experts discuss how to change that.

As news about COVID-19 changes every day and the world awaits the distant promise of a vaccine, healthcare workers are now focused on the daily realities of treating the disease. This is, like everything else about the pandemic, an informational moving target. Every day there are new ideas, new evidence, old possibilities are disproved, and clinicians and researchers in trenches share the benefit of their experiences.

When drug therapy fails to achieve its objectives, it is frustrating for both the patients, whose health and well-being is on the line, and the providers, who believed they were recommending the best possible care.

Everyday there are more news headlines about policymakers addressing different approaches to lowering healthcare and prescription drug costs.

Pharmacists, how many times have you seen a patient pay for more their medication than they should, all because you’re prohibited from telling them about ways to save money?

Happy anniversary!

Since first observing the growing interest in telehealth and remote healthcare, I haven’t tempered my enthusiasm for the field or the collaborative role for pharmacy.